Estimating Survival in Patients with Skeletal Metastases Using PATHFx: An Adaptive, Validated, Clinical Decision Support Tool

Jonathan A. Forsberg*, Rikard Wedin

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Scopus citations

Abstract

We are in the middle of a healthcare revolution. Big data including demographics, molecular markers, and physiologic indicators are being codified by advanced techniques in information technology. The result is an explosion in the number of prognostic models that have been applied to a variety of clinical problems. Given that mobile or otherwise interconnected applications are ubiquitous in modern society, physicians may be tempted to confuse fingertip availability and relative ease of use with a tool that has been properly vetted for clinical use. It would seem that tech-savvy doctors are abandoning their healthy skepticism that has been ingrained by years of journal clubs, academic medicine, and/or clinical practice. However, this should not be the case. When using an “app,” physicians should demand the same level of scrutiny and apply the same healthy skepticism as they do for the literature they read, the implants they select, and the medications they prescribe [1].

Original languageEnglish
Title of host publicationManagement of Bone Metastases
Subtitle of host publicationA Multidisciplinary Guide
PublisherSpringer International Publishing
Pages43-48
Number of pages6
ISBN (Electronic)9783319734859
ISBN (Print)9783319734842
DOIs
StatePublished - 1 Jan 2018
Externally publishedYes

Cite this